eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2018
vol. 14
 
Share:
Share:
abstract:
Original paper

Clinical factors predicting blood pressure reduction after catheter-based renal denervation

Krzysztof Bartus
,
Radosław Litwinowicz
,
Jerzy Sadowski
,
Wojciech Zajdel
,
Maciej Brzeziński
,
Magdalena Bartus
,
Paweł Kleczyński
,
Stanislaw Bartus
,
Dhanunjaya Lakkireddy
,
Bogusław Kapelak

Adv Interv Cardiol 2018; 14, 3 (53): 270–275
Online publish date: 2018/09/21
View full text Get citation
 
Introduction
Renal denervation (RD) can lead to a significant and sustained decrease in mean values of arterial blood pressure (BP). However, there is still a subset of patients without a significant BP drop after RD (non-responders).

Aim
To compare characteristics of RD responders to RD non-responders and to identify the clinical predictors of BP reduction.

Material and methods
Thirty-one patients with diagnosed resistant hypertension underwent RD. Three years after RD the analysis of BP reduction was performed in regard to the baseline patient characteristics.

Results
After 3 years’ follow-up a 10% or more reduction of systolic baseline BP was observed in 74% of patients. Ten percent or more reduction of diastolic baseline BP was observed in 71% of patients. Among responders we observed the following risk factors: hypercholesterolemia in 70%, body mass index (BMI) > 30 kg/m2 in 55%, diabetes mellitus in 35%, current smoking in 5%. Comorbidity included coronary artery disease (CAD) in 30%, cardiomyopathy in 10%, chronic obstructive pulmonary disease (COPD) in 10%, renal insufficiency in 10%, and ventricular arrhythmia in 5%. Among non-responders we observed the following risk factors: hypercholesterolemia in 38%, diabetes mellitus type 2 in 38% and BMI > 30 kg/m2 in 86%. Comorbidity included CAD in 50% and cardiomyopathy in 13% of patients.

Conclusions
A 10% reduction of systolic baseline BP was observed in 74% of patients 3 years after renal denervation. Clinical factors like COPD, chronic kidney disease 3a, female sex and hypercholesterolemia increase the chances of effective reduction of BP.

keywords:

hypertension, resistant hypertension, renal denervation

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.